- LYNKED IN Patient Conference 2024
- Multiple Myeloma Patient Symposium
- 2023-2024 EMBRACE MBC Virtual Forum Series
- ASCO® GU 2024
- ASCO® 2023
- COVID-19
- Leukemia
- Lymphoma
- Myeloma
- MDS and MPN
- Breast
- Lung
- Gynecologic
- Genitourinary
- Gastrointestinal
- Colorectal
- Basic Science
- Supportive and Palliative Care
- CNS
- Skin
- Head and Neck
- Business
Playback speed
10 seconds
ASCO® 2024 Insights: "SACI-IO HR+ Trial - Sacituzumab Govitecan +/- Pembro in Patients With HR+/HER2- mBC"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Ana Garrido-Castro
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Ana Garrido-Castro
270 views
June 13, 2024
Login to view comments.
Click here to Login
Breast